Sofwave Receives U.S. Patent for Innovative Technology
Sofwave Medical Ltd, an emerging powerhouse in non-invasive aesthetic medical devices, recently achieved a significant milestone by securing patent protection from the U.S. Patent and Trademark Office. This patent covers a novel approach to treating fat tissue, a sector that is rapidly evolving within aesthetic treatments.
Details of the New Patent
The issued patent outlines a unique system designed for the reduction of fat tissue. This innovative solution generates unfocused ultrasound energy that precisely targets the hypodermis, the deeper skin layer where fat tissues reside. The application of this energy aims to elevate the fat tissue temperature to levels optimal for effective treatment.
Proprietary Cooling Mechanism
One of the standout features of Sofwave's technology is its proprietary cooling mechanism. While the ultrasound energy effectively heats up the fat tissue, this cooling system protects the outer skin layer, preventing any adverse thermal effects. This dual action ensures that the procedure is not only efficient but also safe, offering promising results without compromising patient comfort.
About Sofwave Medical Ltd
Sofwave Medical Ltd is at the forefront of innovative treatments for various aesthetic concerns, employing state-of-the-art technologies. Their flagship technology, SUPERB™, stands for Synchronous Ultrasound Parallel Beam technology, which has received FDA clearance for multiple applications, including wrinkle reduction and skin tightening.
Effective Solutions for Aesthetic Purposes
With their FDA-cleared SUPERB™ technology, Sofwave provides invaluable solutions for both patients and practitioners. Besides facial rejuvenation, the devices are designed to enhance the appearance of lax submental tissue (beneath the chin), improve cellulite, and treat acne scars effectively. Sofwave’s commitment to innovation is evident through the integration of their Pure Impact™ module, which utilizes Electric Muscle Stimulation (EMS) technology for muscle toning.
Contact Information for Inquiries
For any inquiries regarding their innovative solutions, Sofwave Medical Ltd can be reached directly at Info@sofwave.com. Their focus on providing safe, effective, and aesthetic solutions manifests in each product designed for use by medical professionals.
Investor Relations
Interested investors can contact Brian Ritchie at LifeSci Advisors LLC for more information. He can be reached at (212) 915-2578 or via email at britchie@lifesciadvisors.com. Sofwave Medical Ltd's advancements in technology signify a bright future in aesthetic treatments, making it a key player to watch in the industry.
Frequently Asked Questions
What is the significance of the U.S. patent awarded to Sofwave?
The patent signifies a major milestone for Sofwave Medical Ltd, granting them exclusive rights to their innovative fat reduction technology, enhancing their market position.
How does Sofwave's technology treat fat tissue?
Sofwave's technology uses unfocused ultrasound energy to heat and treat fat tissue effectively while employing a cooling mechanism to protect the skin surface from damage.
What other applications does Sofwave's technology have?
The SUPERB™ technology addresses various aesthetic issues, including wrinkle reduction, skin laxity, cellulite improvement, and treatment of acne scars.
Who can patients contact for more information about Sofwave's products?
Patients can contact Sofwave Medical Ltd through their email at Info@sofwave.com for inquiries about their products and treatments.
Who handles investor relations for Sofwave Medical Ltd?
Investor relations inquiries can be directed to Brian Ritchie at LifeSci Advisors LLC, who can be contacted at (212) 915-2578.
